Saltar al contenido
Merck

Structure-activity studies of 5-substituted pyridopyrimidines as adenosine kinase inhibitors.

Bioorganic & medicinal chemistry letters (2001-01-05)
M Cowart, C H Lee, G A Gfesser, E K Bayburt, S S Bhagwat, A O Stewart, H Yu, K L Kohlhaas, S McGaraughty, C T Wismer, J Mikusa, C Zhu, K M Alexander, M F Jarvis, E A Kowaluk
RESUMEN

The synthesis and SAR of a novel series of non-nucleoside pyridopyrimidine inhibitors of the enzyme adenosine kinase (AK) are described. It was found that pyridopyrimidines with a broad range of medium and large non-polar substituents at the 5-position potently inhibited AK activity. A narrower range of analogues was capable of potently inhibiting adenosine phosphorylation in intact cells indicating an enhanced ability of these analogues to penetrate cell membranes. Potent AK inhibitors were found to effectively reduce nociception in animal models of thermal hyperalgesia and persistent pain.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Cyclopropanecarboxaldehyde, 98%